C12Y 303/02
Ether hydrolases
Official title: Ether hydrolases (3.3.2)
C12Y303/02 (Ether hydrolases) appears on 20 US grants and 45 published applications in this corpus.
Search patents in C12Y- Granted patents
- 20
- Published applications
- 45
- Assignees
- 26
- Inventors
- 122
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 3 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 3 | 3 |
| 2016 | 0 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 2 | 2 |
| 2020 | 2 | 4 |
| 2021 | 3 | 3 |
| 2022 | 0 | 3 |
| 2023 | 1 | 3 |
| 2024 | 0 | 4 |
| 2025 | 3 | 2 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 303/02006Leukotriene-a4 hydrolase5
- C12Y 303/0201Soluble epoxide hydrolase5
- C12Y 303/02003Epoxide hydrolase4
- C12Y 303/02009Microsomal epoxide hydrolase , i.e. styreneepoxide hydrolase4
- C12Y 303/02011Cholesterol-5,6-oxide hydrolase1
- C12Y 303/02001Isochorismatase0
- C12Y 303/02002Alkenylglycerophosphocholine hydrolase0
- C12Y 303/02004Trans-epoxysuccinate hydrolase0
Recent patents
- Microbial production of mogrol and mogrosides25 Nov 2025US 12,480,146 B2Manus Bio Inc.
- Microbial production of triterpenoids including mogrosides8 Jul 2025US 12,351,849 B2Manus Bio Inc.
- Biosynthesis of mogrosides25 Feb 2025US 12,234,464 B2Ginkgo Bioworks, Inc.
- Methods of improving cell-based therapy15 Aug 2023US 11,723,929 B2The Regents of the University of California
- Synthetic methods30 Nov 2021US 11,186,558 B2Glaxosmithkline Intellectual Property (No.2) Limited
- Methods for Sample Quality Assessment27 Aug 2026US 2026/0251658 A1SomaLogic Operating Co., Inc.
- Microbial production of mogrol and mogrosides18 Jun 2026US 2026/0167998 A1
- Microbial production of triterpenoids including mogrosides21 May 2026US 2026/0139286 A1Manus Bio Inc.
- Leukotriene a4 hydrolase (lta4h) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome5 Feb 2026US 2026/0036596 A1Roche Diagnostics Operations, Inc.
- Ratio between lta4h and metrnl in the assessment of polycystic ovarian syndrome5 Feb 2026US 2026/0036599 A1Roche Diagnostics Operations, Inc.
Most cited
By later US patents
- Oligonucleotide modulation of arachidonic acid metabolism34US 5,530,114 AIsis Pharmaceuticals, Inc. · 1996
- Nucleic acids and proteins and methods for making and using them18US 8,119,385 B2BP Corporation North America Inc. · 2012
- Enzyme composition and use thereof8US 6,042,823 AAmano Pharmaceuticals Co., Ltd. · 2000
- Mycotoxin-reducing composition7US 9,901,108 B22018
- Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy3US 8,242,170 B2The Regents of the University of California · 2012